Influence of sarcopenia, clinical data, and 2-[18F] FDG PET/CT in outcome prediction of patients with early-stage adenocarcinoma esophageal cancer

Purpose To determine the prognostic value of sarcopenia measurements done on staging 2-[18F] FDG PET/CT together with metabolic activity of the tumor in patients with adenocarcinoma esophagogastric cancer with surgical treatment. Methods Patients with early-stage, surgically treated esophageal adeno...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of nuclear medicine and molecular imaging 2022-02, Vol.49 (3), p.1012-1020
Hauptverfasser:	Anconina, Reut, Ortega, Claudia, Metser, Ur, Liu, Zhihui Amy, Suzuki, Chihiro, McInnis, Micheal, Darling, Gail E., Wong, Rebecca, Taylor, Kirsty, Yeung, Jonathan, Chen, Eric X., Swallow, Carol J., Bajwa, Jaspreet, Jang, Raymond W., Elimova, Elena, Veit-Haibach, Patrick
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma Adenocarcinoma - complications Adenocarcinoma - diagnostic imaging Body mass Cancer Cardiology Computed tomography Esophageal cancer Esophageal Neoplasms - complications Esophageal Neoplasms - diagnostic imaging Esophageal Neoplasms - therapy Esophagus Female Fluorine isotopes Fluorodeoxyglucose F18 - metabolism Humans Imaging Lean body mass Lymph nodes Male Medical imaging Medicine Medicine & Public Health Metabolism Muscles Nuclear Medicine Oncology Original Article Orthopedics Parameters Patients Positron emission tomography Positron Emission Tomography Computed Tomography Prognosis Radiology Regression analysis Retrospective Studies Sarcopenia Sarcopenia - complications Sarcopenia - diagnostic imaging Skeletal muscle Stomach Neoplasms Tomography, X-Ray Computed Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Purpose To determine the prognostic value of sarcopenia measurements done on staging 2-[18F] FDG PET/CT together with metabolic activity of the tumor in patients with adenocarcinoma esophagogastric cancer with surgical treatment. Methods Patients with early-stage, surgically treated esophageal adenocarcinoma and available pre-treatment 2-[18F] FDG PET/CT were included. The standard uptake value (SUV) and SUV normalized by lean body mass (SUL) were recorded. Skeletal muscle index (SMI) was measured at the L3 level on the CT component of the PET/CT. Sarcopenia was defined as SMI
ISSN:	1619-7070 1619-7089
DOI:	10.1007/s00259-021-05514-w